UPDATE: H.C. Wainwright & Co. Initiates Coverage On Oncothyreon On Significant Upside

By: via Benzinga
In a report published Tuesday, H.C. Wainwright & Co. analyst Reni Benjamin initiated coverage on Oncothyreon (NASDAQ: ONTY) with a Buy ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.